Sandip Kapadia
CIK 1677141 · CHIEF FINANCIAL OFFICER · last filed 2026-05-21
Sandip Kapadia is a CHIEF FINANCIAL OFFICER who has filed 61 SEC Form 4 insider transactions across 3 companies since 2016. The most recent filing, for HRMY, was dated Jul 2, 2026. Across all open-market trades the lifetime net is −$4.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $877.1K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$877.1K
3
61
-$4.11M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PASG | Director | 0 | $4.57 | $0 | $84.0K | 9 | 2026-05-21 |
| HRMY | CHIEF FINANCIAL OFFICER | 24,521 | $35.77 | $877.1K | -$3.89M | 17 | 2026-01-28 |
| INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | CFO and Treasurer | 40,964 | $19.00 | $778.3K | -$306.3K | 19 | 2021-01-26 |
Recent Filings
61 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-02 | HRMY | Notice (144) | −25,000 | -$924.0K | EDGAR |
| 2026-06-30 | HRMY | Notice (144) | −50,000 | -$1.80M | EDGAR |
| 2026-06-26 | HRMY | Notice (144) | −45,594 | -$1.61M | EDGAR |
| 2026-06-24 | HRMY | Notice (144) | −4,406 | -$154.3K | EDGAR |
| 2026-06-09 | HRMY | Notice (144) | −27,960 | -$943.3K | EDGAR |
| 2026-06-05 | HRMY | Notice (144) | −2,101 | -$69.5K | EDGAR |
| 2026-06-04 | HRMY | Notice (144) | −7,064 | -$233.2K | EDGAR |
| 2026-05-21 | PASG | Grant (A) | — | $0 | EDGAR |
| 2026-05-08 | HRMY | Notice (144) | −45,481 | -$1.43M | EDGAR |
| 2026-01-28 | HRMY | Sell (S) | −3,746 | -$139.2K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.